General Information of the Compound
| Compound ID |
CP0005674
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(Z)-1H,1''H-[2,3'']Biindolylidene-3,2''-dione 3-oxime
Show/Hide
|
||||||||||||||||||
| Synonyms |
(Z)-1H,1'H-[2,3']BIINDOLYLIDENE-3,2'-DIONE-3-OXIME
160807-49-8
3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-2H-indol-2-one
3-[3-(Hydroxyamino)-1H-indol-2-yl]indol-2-one
667463-82-3
BiomolKI_000070
CHEBI:43645
CHEMBL126077
CHEMBL216543
INDIRUBIN-3'-MONOXIME
IXM
Indirubin 3'-monoxime
Indirubin 3-oxime
Indirubin-3
Indirubin-3&
Indirubin-3'-monoxime
Indirubin-3-monoxime
Indirubin-3-oxime
Indirubin-3monoxime
SR-01000075929
Tocris-1813
UNM-0000305771
indirubin-3'-monooxime
indirubin-3'-oxime
indirubin-3-oxime
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H11N3O2
|
||||||||||||||||||
| Molecular Weight |
277.283
|
||||||||||||||||||
| Canonical SMILES |
Oc1[nH]c2ccccc2c1-c1[nH]c2ccccc2c1N=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H11N3O2/c20-16-13(9-5-1-3-7-11(9)18-16)15-14(19-21)10-6-2-4-8-12(10)17-15/h1-8,17-18,20H
Show/Hide
|
||||||||||||||||||
| InChIKey |
FQCPPVRJPILDIK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Indirubin-3'-monoxime )
| Drug Name | Indirubin-3'-monoxime | ||
|---|---|---|---|
| Target(s) | |||